Covista/$CVSA
1D1W1MYTD1Y5YMAX
About Covista
Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.
- Ticker
- $CVSA
- Sector
- Consumer Discretionary
- Primary listing
- NYSE
- Employees
- 4,754
- Headquarters
- Chicago, United States
- Website
- www.covista.com
Covista Metrics
BasicAdvanced
$4.5B
18.78
$7.05
0.62
-
Price and volume
Market cap
$4.5B
Beta
0.62
52-week high
$156.26
52-week low
$86.97
Average daily volume
350K
Financial strength
Current ratio
1.093
Quick ratio
0.965
Long term debt to equity
59.854
Total debt to equity
62.613
Interest coverage (TTM)
8.58%
Profitability
EBITDA (TTM)
444.775
Gross margin (TTM)
57.34%
Net profit margin (TTM)
12.87%
Operating margin (TTM)
19.94%
Effective tax rate (TTM)
22.53%
Revenue per employee (TTM)
$410,000
Management effectiveness
Return on assets (TTM)
8.45%
Return on equity (TTM)
18.57%
Valuation
Price to earnings (TTM)
18.777
Price to revenue (TTM)
2.373
Price to book
3.11
Price to tangible book (TTM)
-16.72
Price to free cash flow (TTM)
11.809
Free cash flow yield (TTM)
8.47%
Free cash flow per share (TTM)
11.206
Growth
Revenue change (TTM)
9.27%
Earnings per share change (TTM)
13.95%
3-year revenue growth (CAGR)
10.44%
10-year revenue growth (CAGR)
6.11%
3-year earnings per share growth (CAGR)
51.02%
10-year earnings per share growth (CAGR)
63.26%
What the Analysts think about Covista
Analyst ratings (Buy, Hold, Sell) for Covista stock.
Covista Financial Performance
Revenues and expenses
Covista Earnings Performance
Company profitability
Covista News
AllArticlesVideos
Covista Names Emily C. Chiu and Leslie Storms to its Board of Directors
Business Wire1 month ago
Covista and the Covista Foundation Commit $10 Million and 50,000 Volunteer Hours to Build and Sustain the Healthcare Workforce
Business Wire2 months ago
Covista and Advocate Health Launch Strategic Nursing Collaboration to Strengthen Workforce Readiness and Expand Patient Access
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.